Palisaded Neutrophilic and Granulomatous Dermatitis-Like Reaction Associated with Wilms Tumor 1 Protein-Derived Peptide Vaccine: A Case and Review of the Literature
DOI:
https://doi.org/10.18061/ad.v2i1.9639Keywords:
Palisaded neutrophilic and granulomatous disease, experimental vaccine, cancer vaccineAbstract
Palisaded neutrophilic and granulomatous dermatitis (PNGD) is an inflammatory cutaneous reaction that is associated with underlying autoimmune diseases. In rare cases, PNGD has been attributed to systemic medications. Here we report one case of a cutaneous injection-site reaction that occurred after intradermal administration of an experimental Wilms Tumor 1 (WT1) protein-derived peptide vaccine in a woman being treated for recurrent ovarian cancer. This is the first reported case of a PNGD-like reaction associated with immunotherapy injections. In this article, we discuss this case and summarize the literature related to the diagnosis and management of PNGD, as well as other injection site reactions related to immunotherapies and experimental vaccines.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Lucy Rose, Michela Paradiso, Jose Plaza, David M. O'Malley, Brittany Dulmage

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This Author Agreement for Academic Dermatology ("Agreement") is entered into by and between The Ohio State University, on behalf of its University Libraries ("Publisher") and the author ("Author").
For good and valuable consideration, Publisher and Author agree as follows:
1. Author hereby grants to Publisher the right to publish, reproduce, distribute, translate, transmit and display his/her submitted work and an abstract thereof ("Work") in the Academic Dermatology